| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.24 | 3e-07 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.22 | 2e-06 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.13 | 0.007 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.089 | 0.04 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.078 | 0.09 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.077 | 0.1 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.064 | 0.2 |